MX2019013161A - Personalized immunotherapy against several neuronal and brain tumors. - Google Patents

Personalized immunotherapy against several neuronal and brain tumors.

Info

Publication number
MX2019013161A
MX2019013161A MX2019013161A MX2019013161A MX2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A
Authority
MX
Mexico
Prior art keywords
present
tumor
relates
brain tumors
against several
Prior art date
Application number
MX2019013161A
Other languages
Spanish (es)
Inventor
Weinschenk Toni
fritsche Jens
Walter Steffen
Singh Harpreet
Song Colette
Hilf Norbert
Schorr Oliver
KUTTRUFF-COQUI Sabrina
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1319446.9A external-priority patent/GB201319446D0/en
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of MX2019013161A publication Critical patent/MX2019013161A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
MX2019013161A 2013-11-04 2016-05-04 Personalized immunotherapy against several neuronal and brain tumors. MX2019013161A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361899680P 2013-11-04 2013-11-04
GBGB1319446.9A GB201319446D0 (en) 2013-11-04 2013-11-04 Personalized immunotherapy against several neuronal and brain tumors

Publications (1)

Publication Number Publication Date
MX2019013161A true MX2019013161A (en) 2020-02-03

Family

ID=70386385

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013161A MX2019013161A (en) 2013-11-04 2016-05-04 Personalized immunotherapy against several neuronal and brain tumors.

Country Status (2)

Country Link
JP (1) JP6963836B2 (en)
MX (1) MX2019013161A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2338907T3 (en) * 2007-07-27 2016-03-31 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
PT2172211E (en) * 2008-10-01 2015-03-09 Immatics Biotechnologies Gmbh Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers
GB201319446D0 (en) * 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors

Also Published As

Publication number Publication date
JP6963836B2 (en) 2021-11-10
JP2020062025A (en) 2020-04-23

Similar Documents

Publication Publication Date Title
MX2016005866A (en) Personalized immunotherapy against several neuronal and brain tumors.
PH12015502638A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PH12019502194A1 (en) Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MA39907A (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
WO2015193359A3 (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll)
MX338294B (en) Novel immunotherapy against several tumors including neuronal and brain tumors.
MX2010001086A (en) Novel immunotherapy against neuronal and brain tumors.
PH12016502008A1 (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml)
MX2019013161A (en) Personalized immunotherapy against several neuronal and brain tumors.
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY193910A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc
MY194241A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC
EA201990696A1 (en) PERSONALIZED IMMUNOTHERAPY OF SEVERAL SPECIES OF NEURAL TUMORS AND BRAIN TUMORS
EA202090822A2 (en) A NEW METHOD FOR IMMUNOTHERAPY OF SEVERAL TUMORS OF TUMORS SUCH AS LUNG CANCER, INCLUDING NSCLC